Cargando…

Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study

BACKGROUND: Invasive fungal disease (IFD) is a severe complication after haploidentical stem cell transplantation (haplo-HSCT) and has a poor prognosis. It has been shown that genetic polymorphism may be one possible reason for the increased risk of IFD. This study aimed to assess the role of geneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chen, Zhao, Xiao-Su, Xu, Lan-Ping, Zhang, Xiao-Hui, Huang, Xiao-Jun, Sun, Yu-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962575/ https://www.ncbi.nlm.nih.gov/pubmed/35346077 http://dx.doi.org/10.1186/s12879-022-07298-2

Ejemplares similares

Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
por: Rocha, Susana, et al.
Publicado: (2021)

Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
por: Yu, Xing-Xing, et al.
Publicado: (2022)

Dengue virus transmission from donor to recipient during haploidentical stem cell transplantation
por: Yadav, Anjali, et al.
Publicado: (2021)

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia
por: Wang, Jing-Zhi, et al.
Publicado: (2021)

How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
por: Chang, Ying-Jun, et al.
Publicado: (2016)

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
por: Chang, Ying-Jun, et al.
Publicado: (2020)

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients
por: Lu, Wenyi, et al.
Publicado: (2022)

Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

Haploidentical Family Donor Transplantation: At the Crossroads of a Changing Paradigm
por: Chakrabarti, Suparno, et al.
Publicado: (2016)

Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C
por: Harada, Nobuhiro, et al.
Publicado: (2014)

CML-005: Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with a Donor and Recipient with SARS-CoV-2 Infection
por: Ali, Gadallah, et al.
Publicado: (2021)

Current status of haploidentical stem cell transplantation for leukemia
por: Huang, Xiao-jun
Publicado: (2008)

236 Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant
por: Liberio, Nicole, et al.
Publicado: (2022)

Epidemiology and Prognosis of Invasive Fungal Disease in Chinese Lung Transplant Recipients
por: Ju, Chunrong, et al.
Publicado: (2021)

Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
por: Castagna, Luca, et al.
Publicado: (2020)

Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study
por: Ling, Qi, et al.
Publicado: (2015)

Graft Failure in Patients With Hematological Malignancies: A Successful Salvage With a Second Transplantation From a Different Haploidentical Donor
por: Sun, Yu-Qian, et al.
Publicado: (2021)

PTX3 Polymorphisms Influence Cytomegalovirus Reactivation After Stem-Cell Transplantation
por: Campos, Cláudia F., et al.
Publicado: (2019)

Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation
por: Chang, Ying-Jun, et al.
Publicado: (2019)

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
por: Ciceri, Fabio, et al.
Publicado: (2011)

Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy
por: Zou, Jun, et al.
Publicado: (2022)

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease
por: Chu, Yaya, et al.
Publicado: (2022)

A meta-analysis of MDR1 polymorphisms rs1128503 and rs1045642 and susceptibility to hepatocellular carcinoma
por: Chang, Qing, et al.
Publicado: (2019)

Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma
por: Wei, Ruowen, et al.
Publicado: (2023)

Disseminated Nocardia cyriacigeorgia causing pancreatitis in a haploidentical stem cell transplant recipient
por: Chen, Jason, et al.
Publicado: (2017)

HLA-G Polymorphism (rs16375) and Acute Rejection in Liver Transplant Recipients
por: Azarpira, Negar, et al.
Publicado: (2014)

Living Donor Intestinal Transplantation: Recipient Outcomes
por: Wu, Guosheng, et al.
Publicado: (2022)

Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2016)

Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation
por: Luo, Xiao-Hua, et al.
Publicado: (2014)

Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation
por: Pruitt, Aaron, et al.
Publicado: (2023)

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
por: Bailén, Rebeca, et al.
Publicado: (2021)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
por: Xu, Lan-Ping, et al.
Publicado: (2019)

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
por: Chang, Ying-Jun, et al.
Publicado: (2015)

Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
por: Uz, Burak, et al.
Publicado: (2012)

Comment on: Disseminated Nocardia cyriacigeorgia causing pancreatitis in a haploidentical stem cell transplant recipient
por: Keikha, Masoud
Publicado: (2017)

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients
por: Lehrnbecher, Thomas, et al.
Publicado: (2013)

Invasive Fungal Diseases in Kidney Transplant Recipients: Risk Factors for Mortality
por: Seok, Hyeri, et al.
Publicado: (2020)

Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor
por: Lv, Weiran, et al.
Publicado: (2017)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5j5gjdg1q2d82ni8cednn7trdf